390 related articles for article (PubMed ID: 28760709)
1. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
[TBL] [Abstract][Full Text] [Related]
2. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
Bengtsson S; Bjelkenbrant C; Kahlmeter G
Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of Kingella kingae isolates from respiratory carriers and patients with invasive infections.
Yagupsky P; Katz O; Peled N
J Antimicrob Chemother; 2001 Feb; 47(2):191-3. PubMed ID: 11157905
[TBL] [Abstract][Full Text] [Related]
4. In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections.
Maher JM; Mendes RE; Huynh HK; Porsch EA; St Geme Iii JW; Yagupsky P; Bradley J
Pediatr Infect Dis J; 2023 Mar; 42(3):206-211. PubMed ID: 36728824
[TBL] [Abstract][Full Text] [Related]
5. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
Matuschek E; Brown DF; Kahlmeter G
Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
[TBL] [Abstract][Full Text] [Related]
6. Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints.
Karatuna O; Matuschek E; Åhman J; Caidi H; Kahlmeter G
J Antimicrob Chemother; 2024 Feb; 79(2):375-382. PubMed ID: 38158720
[TBL] [Abstract][Full Text] [Related]
7. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
8. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
[TBL] [Abstract][Full Text] [Related]
9. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
10. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.
Koeth LM; Matuschek E; Kahlmeter G; Stone G
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1047-1053. PubMed ID: 29603034
[TBL] [Abstract][Full Text] [Related]
11. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase production by Kingella kingae in Israel is clonal and common in carriage organisms but rare among invasive strains.
Yagupsky P; Slonim A; Amit U; Porat N; Dagan R
Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1049-53. PubMed ID: 23479041
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of Kingella kingae isolates from children with skeletal system infections.
Yagupsky P
Pediatr Infect Dis J; 2012 Feb; 31(2):212. PubMed ID: 22252209
[No Abstract] [Full Text] [Related]
14. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
[TBL] [Abstract][Full Text] [Related]
15. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
Torumkuney D; Anwar S; Nizamuddin S; Malik N; Morrissey I
J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i76-i87. PubMed ID: 32337594
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.
García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Oteo J; Campos J
J Antimicrob Chemother; 2013 Jan; 68(1):159-63. PubMed ID: 23034712
[TBL] [Abstract][Full Text] [Related]
17. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Listeria monocytogenes isolates from human cases in northern Italy, 2008-2010: MIC determination according to EUCAST broth microdilution method.
Madeo M; Musumeci R; Careddu AM; Amato E; Pontello MM; Cocuzza CE
J Chemother; 2015 Aug; 27(4):201-6. PubMed ID: 24720267
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations.
Bixby ML; Salay JM; Krueger AR; Mathers AJ; Hirsch EB
Microbiol Spectr; 2023 Mar; 11(2):e0336322. PubMed ID: 36877020
[TBL] [Abstract][Full Text] [Related]
20. Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.
Koeth LM; Apfalter P; Becker K; Gesu G; Martínez-Martínez L; Lahiri SD; Alm RA; Ambler J; Iaconis J
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):452-8. PubMed ID: 27233426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
